TheraRadar
Data updated: May 26, 2026

E-Z-CAT DRY (barium sulfate)

Other Approved 2016-01-11
Jump to: Indications Approvals Trials Competitors Safety Patents
4
Indications
--
Phase 3 Trials
10
Years on Market

Details

Status
Discontinued
First Approved
2016-01-11
Routes
ORAL
Dosage Forms
FOR SUSPENSION

Companies

BRACCO
Active Ingredient: BARIUM SULFATE

E-Z-CAT DRY Approval History

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
5 FDA actions from 2016 to 2019 · 3 indication expansions
Apr 2019 SUPPL
Efficacy
FDA Letter Label
Apr 2017 SUPPL
Efficacy
FDA Letter Label
Feb 2017 SUPPL
Label · Labeling
FDA Letter Label

What E-Z-CAT DRY Treats

4 FDA approvals

Originally approved for its first indication in 2016 . Covers 4 distinct patient populations.

  • Other (4)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

E-Z-CAT DRY FDA Label Details

Track E-Z-CAT DRY with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: NDA208036 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.